In the series by Peng et al., a comparison with 144 CMML patients without NPM1 mutations documented that NPM1-mutated cases presented more severe anemia, higher BM monocyte percentage, an increased tendency to AML progression and shorter OS, although these two latter comparisons did not reach statistical significance [71]. This evidence concerns the gene NPM1 and acute myeloid leukemia.